PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

Pfizer's Tanezumab receives almost unanimous rejection by FDA Adcom, page-4

  1. 97 Posts.
    lightbulb Created with Sketch. 9
    I would like to see a $100 a share offer or a distribution deal. Which is what this could be in a few years. Let's not sell ourselves too cheap. With no other real option other than opioids people with OA need iPPS. The whole world needs iPPS.
    DYOR
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.